{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T11:47:42Z","timestamp":1790423262922,"version":"4.1.0"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2013,12,20]],"date-time":"2013-12-20T00:00:00Z","timestamp":1387497600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Drugs Aging"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1007\/s40266-013-0143-3","type":"journal-article","created":{"date-parts":[[2013,12,19]],"date-time":"2013-12-19T12:10:07Z","timestamp":1387455007000},"page":"125-129","source":"Crossref","is-referenced-by-count":28,"title":["Medication for Alzheimer\u2019s Disease and Associated Fall Hazard: A Retrospective Cohort Study from the Alzheimer\u2019s Disease Neuroimaging Initiative"],"prefix":"10.1007","volume":"31","author":[{"given":"Noam U.","family":"Epstein","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin R.","family":"Farlow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaswinder P.","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morris","family":"Fisher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,12,20]]},"reference":[{"issue":"11","key":"143_CR1","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1001\/jama.1987.03390110068028","volume":"257","author":"DM Buchner","year":"1987","unstructured":"Buchner DM, Larson EB. Falls and fractures in patients with Alzheimer-type dementia. JAMA. 1987;257(11):1492\u20135.","journal-title":"JAMA"},{"issue":"8","key":"143_CR2","doi-asserted-by":"crossref","first-page":"677","DOI":"10.2165\/11538260-000000000-00000","volume":"27","author":"NU Epstein","year":"2010","unstructured":"Epstein NU, Saykin AJ, Risacher SL, Gao S, Farlow MR, Alzheimer\u2019s Disease Neuroimaging Initiative. Differences in medication use in the Alzheimer\u2019s disease neuroimaging initiative: analysis of baseline characteristics. Drugs Aging. 2010;27(8):677\u201386.","journal-title":"Drugs Aging"},{"issue":"6","key":"143_CR3","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1177\/0091270011405665","volume":"52","author":"CS Sterke","year":"2012","unstructured":"Sterke CS, van Beeck EF, van der Velde N, Ziere G, Petrovic M, Looman CW, et al. New insights: dose-response relationship between psychotropic drugs and falls: a study in nursing home residents with dementia. J Clin Pharmacol. 2012;52(6):947\u201355.","journal-title":"J Clin Pharmacol"},{"issue":"5","key":"143_CR4","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1111\/j.1532-5415.2008.01657.x","volume":"56","author":"F Assal","year":"2008","unstructured":"Assal F, Allali G, Kressig RW, Herrmann FR, Beauchet O. Galantamine improves gait performance in patients with Alzheimer\u2019s disease. J Am Geriatr Soc. 2008;56(5):946\u20137.","journal-title":"J Am Geriatr Soc"},{"issue":"2","key":"143_CR5","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/j.1532-5415.2009.02085.x","volume":"57","author":"M Montero-Odasso","year":"2009","unstructured":"Montero-Odasso M, Wells J, Borrie M. Can cognitive enhancers reduce the risk of falls in people with dementia? An open-label study with controls. J Am Geriatr Soc. 2009;57(2):359\u201360.","journal-title":"J Am Geriatr Soc"},{"issue":"3","key":"143_CR6","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.jalz.2011.03.008","volume":"7","author":"MS Albert","year":"2011","unstructured":"Albert MS, DeKosky ST, Dickson D, Dubois B, Feldman HH, Fox NC, et al. The diagnosis of mild cognitive impairment due to Alzheimer\u2019s disease: recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease. Alzheimer\u2019s Dementia. 2011;7(3):270\u20139.","journal-title":"Alzheimer\u2019s Dementia"},{"key":"143_CR7","unstructured":"ADNI procedure manual. http:\/\/www.adni-info.org\/Scientists\/Pdfs\/adniproceduresmanual12.pdf . Accessed 23 Oct 2013."},{"issue":"22","key":"143_CR8","doi-asserted-by":"crossref","first-page":"2716","DOI":"10.1001\/archinte.163.22.2716","volume":"163","author":"DM Fick","year":"2003","unstructured":"Fick DM, Cooper JW, Wade WE, Waller JL, Maclean JR, Beers MH. Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts. Arch Intern Med. 2003;163(22):2716\u201324.","journal-title":"Arch Intern Med"},{"issue":"10","key":"143_CR9","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1007\/s12603-009-0247-y","volume":"13","author":"T Voisin","year":"2009","unstructured":"Voisin T, Sourdet S, Cantet C, Andrieu S, Vellas B. Descriptive analysis of hospitalizations of patients with Alzheimer\u2019s disease: a two-year prospective study of 686 patients from the REAL.FR study. J Nutr Health Aging. 2009;13(10):890\u20132.","journal-title":"J Nutr Health Aging"},{"issue":"7","key":"143_CR10","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1111\/j.1532-5415.1987.tb04341.x","volume":"35","author":"ME Tinetti","year":"1987","unstructured":"Tinetti ME. Factors associated with serious injury during falls by ambulatory nursing home residents. J Am Geriatr Soc. 1987;35(7):644\u20138.","journal-title":"J Am Geriatr Soc"},{"issue":"1","key":"143_CR11","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1097\/PHM.0b013e31823caeea","volume":"91","author":"P Suttanon","year":"2012","unstructured":"Suttanon P, Hill KD, Said CM, Logiudice D, Lautenschlager NT, Dodd KJ. Balance and mobility dysfunction and falls risk in older people with mild to moderate Alzheimer disease. Am J Phys Med Rehabil. 2012;91(1):12\u201323.","journal-title":"Am J Phys Med Rehabil"},{"issue":"9","key":"143_CR12","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1002\/pds.1620","volume":"17","author":"A Gallini","year":"2008","unstructured":"Gallini A, Sommet A, Montastruc JL, French PharmacoVigilance Network. Does memantine induce bradycardia? A study in the French PharmacoVigilance Database. Pharmacoepidemiol Drug Saf. 2008;17(9):877\u201381.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"8","key":"143_CR13","doi-asserted-by":"crossref","first-page":"687","DOI":"10.2165\/00002512-200522080-00005","volume":"22","author":"P Bordier","year":"2005","unstructured":"Bordier P, Lanusse S, Garrigue S, Reynard C, Robert F, Gencel L, et al. Causes of syncope in patients with Alzheimer\u2019s disease treated with donepezil. Drugs Aging. 2005;22(8):687\u201394.","journal-title":"Drugs Aging"},{"issue":"3","key":"143_CR14","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1212\/WNL.57.3.481","volume":"57","author":"RC Mohs","year":"2001","unstructured":"Mohs RC, Doody RS, Morris JC, Ieni JR, Rogers SL, Perdomo CA, et al. A 1-year, placebo-controlled preservation of function survival study of donepezil in AD patients. Neurology. 2001;57(3):481\u20138.","journal-title":"Neurology"},{"issue":"7","key":"143_CR15","doi-asserted-by":"crossref","first-page":"577","DOI":"10.2165\/00002018-200831070-00003","volume":"31","author":"MR Farlow","year":"2008","unstructured":"Farlow MR, Graham SM, Alva G. Memantine for the treatment of Alzheimer\u2019s disease: tolerability and safety data from clinical trials. Drug Saf. 2008;31(7):577\u201385.","journal-title":"Drug Saf"},{"issue":"6","key":"143_CR16","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1111\/j.1532-5415.2011.03450.x","volume":"59","author":"DH Kim","year":"2011","unstructured":"Kim DH, Brown RT, Ding EL, Kiel DP, Berry SD. Dementia medications and risk of falls, syncope, and related adverse events: meta-analysis of randomized controlled trials. J Am Geriatr Soc. 2011;59(6):1019\u201331.","journal-title":"J Am Geriatr Soc"},{"key":"143_CR17","doi-asserted-by":"crossref","unstructured":"Birks J. Cholinesterase inhibitors for Alzheimer\u2019s disease. Cochrane Database Syst Rev 2006;(1):CD005593.","DOI":"10.1002\/14651858.CD005593"}],"container-title":["Drugs & Aging"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40266-013-0143-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40266-013-0143-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40266-013-0143-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,5]],"date-time":"2019-08-05T04:35:33Z","timestamp":1564979733000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40266-013-0143-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12,20]]},"references-count":17,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,2]]}},"alternative-id":["143"],"URL":"https:\/\/doi.org\/10.1007\/s40266-013-0143-3","relation":{},"ISSN":["1170-229X","1179-1969"],"issn-type":[{"value":"1170-229X","type":"print"},{"value":"1179-1969","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,12,20]]}}}